Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
Authors:
- Anastasios KarayiannakisAKAnastasios Karayiannakis
- Dimitrios MatthaiosDMDimitrios Matthaios
- Heleni BolanakiHBHeleni Bolanaki
- Gregorios TripsianisGTGregorios Tripsianis
- Antonios Apostolos TentesATAntonios Apostolos Tentes
- Evi LianidouEvi Lianidou
- Ekaterini ChatzakiECEkaterini Chatzaki
- Aliki FiskaAFAliki Fiska
- Maria LambropoulouMLMaria Lambropoulou
- George KoliosGKGeorge Kolios
- Stylianos KakolyrisSKStylianos Kakolyris
- 1 January 2013
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 51 (7) , 1505-10
Abstract
DNA methylation represents one of the most common epigenetic changes in human cancer providing important information regarding carcinogenesis. A possible role as a prognostic indicator has also been proposed. The aim of our study was to evaluate the prognostic significance of SOX17 promoter methylation status in patients with operable gastric cancer. Using methylation-specific PCR (MSP) we examined the incidence and prognostic significance of SOX17 methylation status in cell free circulating DNA in the serum of 73 patients with operable gastric cancer. Fifty-one patients were male (69.9%), their median age was 65 years, 43 patients (58.9%) had regional lymph node involvement and all had a Performance Status (WHO) of 0-1. SOX17 promoter was found to be methylated in 43 out of 73 gastric cancer serum samples examined (58.9%). All 20 control serum samples from healthy individuals were negative. Overall survival (OS) was found to be significantly associated with SOX17 methylation (p=0.049). A significant correlation between methylation status and differentiation (p=0.031) was also observed. No other significant associations between different tumor parameters examined and SOX17 methylation status were observed. SOX17 promoter methylation in cell free DNA of patients with operable gastric cancer is a frequent event and may provide important information regarding prognosis in this group of patients.Keywords
This publication has 11 references indexed in Scilit:
- Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancerTumor Biology, 2011
- Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal CancerCancer Research, 2008
- Sox17 and Sox4 Differentially Regulate β-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma CellsMolecular and Cellular Biology, 2007
- Identification of Sox17 as a Transcription Factor That Regulates Oligodendrocyte DevelopmentJournal of Neuroscience, 2006
- The emerging science of epigenomicsHuman Molecular Genetics, 2006
- Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid NeoplasiasDisease Markers, 2005
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- The fundamental role of epigenetic events in cancerNature Reviews Genetics, 2002
- DNA Alterations in Body Fluids as Molecular Tumor Markers for Urological MalignanciesEuropean Urology, 2002
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971